The following is a listing of all home transfers in Burlington County reported from Aug. 18 to Aug. 24. There were 114 ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

Entrepreneurship competition draws over 50,000 applicants each season, culminating in high-stakes outcomes such as 'Most ...

Catalyst Pharmaceuticals (CPRX) announced that the Company and its licensor SERB S.A. have entered into a Settlement Agreement with Lupin Ltd and ...

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

RBI Governor Sanjay Malhotra expressed hope that India-US trade talks will reach a positive conclusion. Malhotra's remarks come at a time when the sixth round of India-US Bilateral Trade Agreement ...

Indian stock market opened positively as Nifty 50 rose 0.28% and BSE Sensex increased by 0.29%. The market sentiment improved following hints from the U.S. Federal Reserve about potential interest ...

Zee Business Managing Editor Anil Singhvi shares his strategy for the coming session on Dalal Street. Learn more about his ...

Pharma companies are separating consumer healthcare businesses to drive growth, facing challenges in a competitive market.

Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter - see how markets may move next.